Q2 saw a slight sales increase but an organic decline, with EBITDA and margins down year-over-year. Cost-cutting and restructuring are underway to defend profitability, while new bank terms improve financing. Management remains committed to margin targets despite market headwinds.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.